- Report
- April 2023
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- February 2024
- 185 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2023
- 190 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2023
- 71 Pages
India
From €3185EUR$3,500USD£2,731GBP
- Report
- September 2023
- 88 Pages
Israel
From €3185EUR$3,500USD£2,731GBP
- Report
- August 2024
- 80 Pages
Japan
From €3185EUR$3,500USD£2,731GBP
- Report
- August 2024
- 80 Pages
Japan
From €3185EUR$3,500USD£2,731GBP
- Report
- April 2024
- 188 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- April 2024
- 190 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- November 2023
- 190 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- November 2023
- 182 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2023
- 189 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2023
- 178 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2023
- 89 Pages
Japan
From €3185EUR$3,500USD£2,731GBP
- Report
- February 2024
- 110 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- February 2024
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- April 2023
- 110 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- April 2023
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- April 2023
- 110 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- April 2023
- 115 Pages
Global
From €4323EUR$4,750USD£3,706GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more